mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.006 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |